These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8709415)

  • 1. [Plasma allantoin in patients undergoing maintenance hemodialysis].
    Sasaki K; Motomiya Y; Oyama N; Hirao Y; Okajima E; Uji Y; Okabe H
    Nihon Jinzo Gakkai Shi; 1996 Apr; 38(4):164-70. PubMed ID: 8709415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on plasma allantoin in patients undergoing maintenance hemodialysis].
    Motomiya Y; Sasaki K; Okajima E; Uji Y; Okabe H
    Nihon Jinzo Gakkai Shi; 1993 Jul; 35(7):853-8. PubMed ID: 8411765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of allantoin, hypoxanthine, xanthine, and uric acid in serum/plasma by CE.
    Caussé E; Pradelles A; Dirat B; Negre-Salvayre A; Salvayre R; Couderc F
    Electrophoresis; 2007 Feb; 28(3):381-7. PubMed ID: 17177243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
    Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
    Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-2 microglobulin and amyloid osteoarthropathy in patients undergoing chronic hemodialysis].
    Prinseau J; Baglin A; Benoit J; Leparc JM; Got C; Louis MF; Attar B; Fritel D
    Ann Med Interne (Paris); 1989; 140(2):94-8. PubMed ID: 2662855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of antioxidant properties of uric acid in humans for a consideration measuring of levels of allantoin in plasma by liquid chromatography.
    Kand'ár R; Záková P; Muzáková V
    Clin Chim Acta; 2006 Mar; 365(1-2):249-56. PubMed ID: 16194528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new role of uric acid as an antioxidant in human plasma].
    Hasegawa T; Kuroda M
    Rinsho Byori; 1989 Sep; 37(9):1020-7. PubMed ID: 2607655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
    Alhomida AS
    Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
    Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
    Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of serum levels of beta-2-microglobulin in dialysis patients].
    Baldrati L; Baldrati L; Delvecchio C; Capponcini C; Docci D; Turci F; Feletti C
    Recenti Prog Med; 1990 Sep; 81(9):561-3. PubMed ID: 2263750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.